Compare LEXX & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
IZEA Worldwide Inc is a create economy, specializing in providing software solutions and professional services that connect brands with a broad spectrum of social influencers and content creators. It's a pioneering marketing technology company that offers cutting-edge software and professional services, empowering brands to engage and transact with a diverse range of social influencers and content creators. Its brands are The Creator Marketplace, IZEA Flex, and Full-Service Influencer Marketing. Its geographic areas are North America, APAC, and other.